Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. | Cancer Cell;2(2): 127-37, 2002 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.

Agus, David B; Akita, Robert W; Fox, William D; Lewis, Gail D; Higgins, Brian; Pisacane, Paul I; Lofgren, Julie A; Tindell, Charles; Evans, Douglas P; Maiese, Krista; Scher, Howard I; Sliwkowski, Mark X.

Affiliation

Agus DB; Cedars-Sinai Prostate Cancer Center, Los Angeles, California 90048, USA.

Cancer Cell ; 2(2): 127-37, 2002 Aug.

Article in En | MEDLINE | ID: mdl-12204533

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Signal Transduction / Receptor, ErbB-2 / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2002 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Signal Transduction / Receptor, ErbB-2 / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2002 Document type: Article Affiliation country: Country of publication: